LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 19 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $422,000 | +20.2% | 113,500 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $351,000 | -42.1% | 113,500 | 0.0% | 0.01% | -40.0% |
| Q1 2022 | $606,000 | +9.4% | 113,500 | 0.0% | 0.01% | +42.9% |
| Q4 2021 | $554,000 | -44.8% | 113,500 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $1,004,000 | -3.0% | 113,500 | 0.0% | 0.01% | +10.0% |
| Q2 2021 | $1,035,000 | -78.9% | 113,500 | -62.2% | 0.01% | -78.3% |
| Q1 2021 | $4,914,000 | – | 300,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |